OPRX

Q: What is the price of OptimizeRx (OPRX) today?

The current price of OptimizeRx (OPRX) is $ 4.98, representing a -58.33% gain over the past year. The stock began the year trading around $ 12.26 and is currently priced at $ 4.98. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does OptimizeRx (OPRX) pay dividends?

OptimizeRx (OPRX) did not pay dividends over the past year.

Q: Is OptimizeRx (OPRX) a good investment?

OptimizeRx (OPRX) is currently trading at $ 4.98 with a P/E ratio of 14.16. This represents a 314% premium compared to its historical average P/E. Over the past year, the stock has gained -58.33 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -58.33%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

OptimizeRx Corporation

Price

$ 4.98

return (12m)

-58.33%

p/e

14.16

p/bv

0.75

DIVIDEND YIELD

0.00%

OPRX price

OPRX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment OPRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-30.83%

3 months

-42.29%

1 year

-58.33%

2 years

-61.93%

5 years

-89.81%

10 years

50.91%

Fundamentals OPRX

review the fundamentals of OptimizeRx shares

P/E

14.16

Sector: -1.37 Industry: 11.03

P/S (PSR)

0.90

Sector: 1.93 Industry: 1.54

P/BV

0.75

Sector: 2.08 Industry: 3.18

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: 0.01%

ROA

4.08%

Sector: -26.93% Industry: 3.04%

ROE

5.27%

Sector: -32.98% Industry: 7.23%

ROIC

0.88%

Sector: -433.14% Industry: -4.08%

NET MARGIN

6.36%

Sector: -29.12% Industry: 2.71%

GROSS MARGIN

70.04%

Sector: 45.58% Industry: 30.10%

OPERATING MARGIN

13.58%

Sector: -23.85% Industry: 2.09%

EV/EBITDA

5.08

Sector: 0.05 Industry: 7.65

EV/EBIT

6.56

Sector: -1.20 Industry: 5.96

PRICE-TO-ASSETS

0.58

Sector: 1.14 Industry: 1.45

BVPS

6.82

Sector: 3.93 Industry: 14.79

EPS

0.36

Sector: -0.90 Industry: 1.10

EQUITY-TO-ASSETS RATIO

0.77

Sector: 0.44 Industry: 0.46

LIABILITIES / ASSETS

0.23

Sector: 0.47 Industry: 0.52

CAGR REVENUE 5 YEARS

11.86%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

79.16%

Sector: - Industry: -

FAIR VALUE OF OptimizeRx ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 4.98

Fair Value

$ 0.00

Upside/Downside Return potential.

49.25%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals OPRX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	34.89	28.27	81.02%	0.63%	$ 881.85 B	34.99%
ISRG	52.42	8.87	16.93%	0.00%	$ 156.17 B	28.15%
TMO	24.01	3.16	13.15%	0.40%	$ 164.42 B	15.15%
SNY	6.85	1.22	17.79%	5.28%	$ 102.25 B	14.75%
NVS	21.04	7.31	34.77%	2.08%	$ 284.73 B	23.92%
ABT	24.34	0.00	-%	2.78%	$ 152.79 B	13.91%
MDT	21.50	2.02	9.38%	3.67%	$ 99.20 B	13.00%
GSK	12.78	4.32	33.77%	3.52%	$ 100.27 B	17.79%
CVS	41.68	1.57	3.78%	2.77%	$ 122.20 B	0.72%
BSX	23.45	3.23	13.78%	0.00%	$ 83.60 B	17.29%
TMDX	13.51	4.70	34.80%	0.00%	$ 2.32 B	27.04%
HCA	13.94	-31.80	-228.14%	0.70%	$ 94.70 B	8.89%
IDXX	39.87	28.06	70.38%	0.00%	$ 43.66 B	24.63%
RMD	19.42	4.55	23.41%	1.14%	$ 29.51 B	27.44%
DHR	31.37	2.19	6.97%	0.83%	$ 115.73 B	14.89%
INMD	10.19	1.34	13.18%	0.00%	$ 888.30 M	23.27%
PHG	21.11	1.81	8.56%	3.54%	$ 23.86 B	5.50%
SYK	35.85	5.21	14.52%	1.10%	$ 119.63 B	13.21%
FMS	10.79	0.72	6.71%	3.64%	$ 11.88 B	4.89%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

OPRX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT OptimizeRx

OptimizeRx Corporation

Average Investor10 user rating

4.0 (0 people)

United States

20 years

Founded: 2006

2009

Time since IPO - 17 years

97

Employees

OptimizeRx Corporation (United States) is listed on the Nasdaq and has a market capitalization of $96.71 Millions, with shareholders equity totaling $129.61 Millions.

The company employs approximately 97 people and operates in the Health sector, within the Health Technology industry.

Over the past 12 months, OptimizeRx Corporation reported $107.35 Millions in revenue, generating net income of $6.83 Millions.

Key financial metrics include a P/E ratio of 14.16, a price-to-book (P/B) ratio of 0.75, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker OPRX.

Market cap

$ 96.71 Millions

Net worth

$ 129.61 Millions

$ 129,610,000.00

Assets

$ 167.26 Millions

$ 167,260,000.00

Total Shares Outstanding

19.00 Millions

19,000,000

Average Daily Trading Volume

$ 527.60 Thousand

$ 527,603.70

Sector

Health

Industry

Health Technology

OPRX

OPRX revenue and profits

Financial Results OPRX

DRAG THE FRAME TO SEE MORE DATA

OPRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

CI - Cigna

$ 283.10 --7,05% (12M)

P/E

18.85

2.14%

ROE

18.71%

P/BV

3.53

CVS - CVS Health

$ 93.28 60,54% (12M)

P/E

41.68

2.77%

ROE

3.78%

P/BV

1.57

CNC - Centene

$ 58.28 0,36% (12M)

P/E

-4.45

0.00%

ROE

-29.93%

P/BV

1.33

HUM - Humana

$ 304.10 36,39% (12M)

P/E

32.40

1.16%

ROE

6.06%

P/BV

1.96

SNY - Sanofi

$ 44.67 --7,67% (12M)

P/E

6.85

5.28%

ROE

17.79%

P/BV

1.22

LLY - Eli Lilly

$ 1,018.87 43,77% (12M)

P/E

34.89

0.63%

ROE

81.02%

P/BV

28.27

HCA - HCA Healthcare

$ 396.67 6,22% (12M)

P/E

13.94

0.70%

ROE

-228.14%

P/BV

-31.80

NVS - Novartis

$ 150.45 36,33% (12M)

P/E

21.04

2.08%

ROE

34.77%

P/BV

7.31

CI - Cigna

$ 283.10 --7,05% (12 M)

P/L

18.85

2.14%

ROE

18.71%

P/VP

3.53

CVS - CVS Health

$ 93.28 60,54% (12 M)

P/L

41.68

2.77%

ROE

3.78%

P/VP

1.57

CNC - Centene

$ 58.28 0,36% (12 M)

P/L

-4.45

0.00%

ROE

-29.93%

P/VP

1.33

HUM - Humana

$ 304.10 36,39% (12 M)

P/L

32.40

1.16%

ROE

6.06%

P/VP

1.96

SNY - Sanofi

$ 44.67 --7,67% (12 M)

P/L

6.85

5.28%

ROE

17.79%

P/VP

1.22

LLY - Eli Lilly

$ 1,018.87 43,77% (12 M)

P/L

34.89

0.63%

ROE

81.02%

P/VP

28.27

HCA - HCA Healthcare

$ 396.67 6,22% (12 M)

P/L

13.94

0.70%

ROE

-228.14%

P/VP

-31.80

NVS - Novartis

$ 150.45 36,33% (12 M)

P/L

21.04

2.08%

ROE

34.77%

P/VP

7.31

Frequently Asked Questions

What is the price of OptimizeRx (OPRX) today?

The current price of OptimizeRx (OPRX) is $ 4.98, representing a -58.33% gain over the past year. The stock began the year trading around $ 12.26 and is currently priced at $ 4.98. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does OptimizeRx (OPRX) pay dividends?

OptimizeRx (OPRX) did not pay dividends over the past year.

Is OptimizeRx (OPRX) a good investment?

OptimizeRx (OPRX) is currently trading at $ 4.98 with a P/E ratio of 14.16. This represents a 314% premium compared to its historical average P/E. Over the past year, the stock has gained -58.33 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -58.33%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy OptimizeRx (OPRX) stock?

You can buy OptimizeRx (OPRX) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol OPRX and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of OptimizeRx (OPRX) yield today?

Over the past month, OptimizeRx (OPRX) has returned -30.83% — -58.33% over the past year, and -89.81% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of OptimizeRx (OPRX) today at the current price of $ 4.98 your total investment would be $ 498.00.

Based on historical performance, the investment would have grown to approximately:

$ 207.52 after 1 year
$ 50.75 after 5 years
$ 751.53 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

OPRX

OptimizeRx Corporation

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment OPRX

review the fundamentals of OptimizeRx shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

current DY: 0.00%

5-year average DY: 0.00%

ABOUT OptimizeRx

OptimizeRx Corporation

United States

20 years

2009

97

PROFIT X PRICE OPRX

Financial Results OPRX

OPRX cash flow

Asset, Revenue and Profit Growth - OPRX

OPRX balance sheet

CI - Cigna

CVS - CVS Health

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

CI - Cigna

CVS - CVS Health

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

Frequently Asked Questions